OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients

Keyphrases

• Randomized Clinical Trial 100%
• Growth Hormone 100%
• Hemodialysis Patients 100%
• Maintenance Hemodialysis Patients 100%
• Cardiovascular Events 50%
• Adverse Events 50%
• Life Events 50%
• Quality of Life 50%
• Patient Experience 50%
• Poor Outcome 50%
• High Mortality 50%
• High Morbidity 50%
• Serum Proteins 50%
• Exercise Capacity 50%
• Lean Body Mass 50%
• Recombinant Human Growth Hormone (r-hGH) 50%
• Protein-energy Wasting 50%
• Poor Quality of Life 50%
• Hospitalization Rate 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Clinical Trial 100%
• Growth Hormone 100%
• Hemodialysis 100%
• Adverse Event 33%
• Morbidity 33%
• Human Growth Hormone 33%
• Plasma Protein 33%